CCL5 and dermatitis: An important reduction of MPO activity was observed in a T-cells dependent model of skin inflammation (DNFB-induced CHS) by [44AANA47]-CCL5 at 1 mg/kg (46.6% (53.4% of vehicle) (Fig. 3C).